Hoth Therapeutics Successfully Completes Phase I of In-Life Dose Escalation Study for Treating Eczema Read more
Novartis receives FDA approval for Beovu, offering wet AMD patients vision gains and greater fluid reductions vs aflibercept Read more
GSK and Lyell Immunopharma join forces to develop the next generation of cancer cell therapies Read more
Digital Therapeutics Alliance speaker interview released for Disruptive Technologies in Pharma 2020 Read more
Akcea and Pfizer Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-LRx Read more
Exclusive interview with Optceutics Ltd speaker released for Ophthalmic Drugs Conference 2019 Read more